(Q36230869)

12 August 2017

Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study (English)

1 reference

12 August 2017

M Blane Schilling

1

1 reference

12 August 2017

Connie Parks

series ordinal

2

1 reference

12 August 2017

Robert G Deeter

series ordinal

3

1 reference

12 August 2017

30 June 2011

1 reference

Experimental and Therapeutic Medicine

12 August 2017

1 reference

12 August 2017

2

1 reference

12 August 2017

5

1 reference

12 August 2017

859-866

1 reference

describes a project that uses

12 August 2017

SQL

1 reference

26 June 2022

https://europepmc.org/article/PMC/PMC3440789

inferred from PubMed Central ID database lookup

cites work

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Cost effectiveness of treatment options in advanced breast cancer in the UK.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Average relative dose intensity and the impact on design of clinical trials.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440789

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22977589

12 December 2020

inferred from PubMed ID database lookup

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22977589

12 December 2020

inferred from PubMed ID database lookup

Cost of neutropenic complications of chemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22977589

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.3892/ETM.2011.312

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22977589

1 reference